We are live on ! Find out more
IBIO icon

iBio
IBIO

12 hedge funds and large institutions have $197K invested in iBio in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0% → 0% (-0%)

8% less funds holding

Funds holding: 13 → 12 (-1)

16% less capital invested

Capital invested by funds: $234K → $197K (-$37K)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

Holders
12
Holders Change
-1
Holders Change %
-7.69%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$26.9K
2
VF
Virtu Financial
New York
+$20.5K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$14.1K
4
WS
Wedbush Securities
California
+$13.1K
5
LTFS
Ladenburg Thalmann Financial Services
Florida
+$673

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$40K
2
TSS
Two Sigma Securities
New York
-$16K

IBIO Hedge Fund Activity: Q3 2019 in Review

12 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in iBio (IBIO) for Q3 2019, worth a combined $197K — down 16% from $234K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of IBIO and 2 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 4 added.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $26.9K. The largest seller was Citadel Advisors, exiting entirely with an estimated $40K sold.

  • 12 institutional investors held iBio (IBIO) as of Q3 2019, down from 13 in Q2 2019.
  • Funds reported $197K of iBio stock for Q3 2019, down 16% quarter-over-quarter.
  • 2 funds opened new iBio positions in Q3 2019 and 3 closed out, a net change of -1 holder.
  • The largest iBio buyer in Q3 2019 was Renaissance Technologies, an estimated $26.9K added.
  • The largest iBio seller in Q3 2019 was Citadel Advisors, an estimated $40K sold.

Based on aggregated 13F filings for Q3 2019.